Tolerability and Immunogenicity of a Single 40-µg Dose of Recombinant Botulinum Vaccine A/B (rBV A/B) for the Production of BabyBIG in Volunteers With Existing Botulinum Immunity
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2019
Price : $35 *
At a glance
- Drugs Botulism vaccine (Primary)
- Indications Botulism
- Focus Pharmacodynamics
- 11 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 27 Dec 2018 Planned primary completion date changed from 1 Sep 2019 to 1 Oct 2019.
- 27 Dec 2018 Status changed from not yet recruiting to recruiting.